Menu Search
Equities

Genertec Universal Medical Group Co Ltd

5UM:FRA

Genertec Universal Medical Group Co Ltd

Actions
  • Price (EUR)0.446
  • Today's Change0.00 / 0.00%
  • Shares traded25.00k
  • 1 Year change-2.62%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 08:14 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Genertec Universal Medical Group Co Ltd, formerly Universal Medical Financial & Technical Advisory Services Co Ltd, is a company engaged in healthcare business. The Company mainly operates through two segments. The Finance Business segment mainly includes direct finance leasing, sale and leaseback, factoring, operating leases and advisory services. The Healthcare Business segment mainly includes healthcare services, hospital operation management and medical equipment import and export trade and domestic trade, equipment full cycle management and medical digital technology services. The Company mainly conducts business in China.

  • Revenue in HKD (TTM)14.95bn
  • Net income in HKD2.28bn
  • Incorporated2012
  • Employees21.52k
  • Location
    Genertec Universal Medical Group Co Ltd4th, 5th, 13th Floor, Hardmen Square, BuBEIJING ChinaCHN
  • Websitehttps://www.umcare.cn/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.